Hang Lee, PhD

Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• ORF34-08 - Three Versus Twelve Months of Romosozumab for Postmenopausal Osteoporosis: The Limited Duration Anabolic Therapy (LIDA) Randomized Controlled Trial

  Sunday, June 14, 2026
  3:00 PM - 3:15 PM CT

• MON-795 - Zoledronic Acid Maintains Gains in Spine and Hip Bone Mineral Density Achieved with Romosozumab in Women with Anorexia Nervosa

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF46-05 - Coagulation and Vascular Function in Transgender and Gender-Diverse Adults on Estrogen-Dominant Gender-Affirming Hormone Therapy

  Monday, June 15, 2026
  2:45 PM - 3:00 PM CT